Three sizable IPOs priced this past week, joined by a flurry of small issuers and blank check companies - Ingram Micro, ...

For a drugmaker advancing medicines through clinical trials, time is the enemy: the longer the process takes, the more costs ...

Yet, one analyst told Barron’s that “rarely in my 20 years as an analyst have I seen a company with so much potential.” He ...

Investing in Cabaletta Bio for potential high returns on innovative CAR-T therapies despite volatility and risk. Click here ...

The crisis that has swept the biotech sector crashed into Medpace Holdings on Tuesday, sending shares of the drug-testing ...

The key challenges in space missions are the continuous availability of nutrients, preservation of food, microgravity and radiation, health hazards such as cancers, cataracts, bone and muscle loss amo ...

Septerna CEO Jeffrey Finer rang the opening bell on the Nasd | South San Francisco-based Septerna has scored with an upsized ...

If Kevin and Stephanie Ness collect their $15 million asking price for the home on Sunset Blvd., it will be the second time ...

Discover top biotech associations that drive industry growth through collaboration, networking, and strategic partnerships ...

ISRO & Department of Biotechnology have come together to conduct a series of biotech experiments in space, some of which are ...

North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global ...

The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...